WORLD SMART
BIOPROCESSING: PHARMA 4.0

SUMMIT

14th -16th April 2021 | Berlin, Germany

THE WORLD SMART BIOPROCESSING: PHARMA 4.0 SUMMIT WILL GATHER WORLD TECHNOLOGY LEADERS FROM PHARMA, BIOTECH, AND PHARMA SUPPLIERS TO SHARE CASE STUDIES AND INTERACTIVE BREAKOUTS TOWARDS COMMERCIAL PROGRESS

Connect with global scientists, engineers and executives working across the entire spectrum of biopharmaceutical development and production.

>Our Speakers<

Gerald Gellermann

Senior Fellow & Analytical Project Leader in Analytical Development

Novartis

 

Vicky Goralczyk

Director Cell Line and
Bioprocess Development

Glycotope

 

Bjørn Gunnar Voldborg

Director of CHO Cell
Line Development

Technical University of Denmark

 

Lénaïg Savary

BioManufacturing
Senior Engineer

MERCK

 

Anne Richelle

Senior Specialist
Metabolic Modeling

GSK

 

Wolfgang Sommeregger

Process Engineer

Bilfinger Industrietechnik Salzburg

 

Gerald Gellermann

Senior Fellow & Analytical Project
Leader in Analytical Development

Novartis

 

Vicky Goralczyk

Director Cell Line and
Bioprocess Development

Glycotope

 

Bjørn Gunnar Voldborg

Director of CHO Cell
Line Development

Technical University of Denmark

 

Gerald Gellermann

Senior Fellow & Analytical Project
Leader in Analytical Development

Novartis

Vicky Goralczyk

Director Cell Line and
Bioprocess Development

Glycotope

Wolfgang Sommeregger

Process Engineer

Bilfinger

Industrietechnik Salzburg

Bjørn Gunnar Voldborg

Director of CHO Cell
Line Development

Technical University of Denmark

Lénaïg Savary

BioManufacturing
Senior Engineer

MERCK

 

Anne Richelle

Senior Specialist
Metabolic Modeling

GSK

Lénaïg Savary

BioManufacturing
Senior Engineer

MERCK

Anne Richelle

Senior Specialist
Metabolic Modeling

GSK

 

Wolfgang Sommeregger

Process Engineer

Bilfinger

Industrietechnik Salzburg

Peter Neubauer  

Professor for Bioprocess
Engineering

Berlin Institute of Technology

 

Mark Duerkop

Chief Executive Officer

Novasign

 

 

Christoph Herwig

Professor of Bioprocessing Engineering

Vienna University of Technology

 

Barbara Kraus

Head of Gene Therapy Process Development

Takeda

Ulrich Rümenapp

Head of Launch Preparation

Bayer

 

Philip Probert

Head of Technical

CPI Bioloigics

 

Peter Neubauer  

Professor for Bioprocess
Engineering

Berlin Institute of Technology

 

Mark Duerkop

Chief Executive Officer

Novasign

 

Christoph Herwig

Professor of Bioprocessing
Engineering

Vienna University of Technology

 

Peter Neubauer  

Professor for Bioprocess
Engineering

Berlin Institute of Technology

 

Mark Duerkop

Chief Executive Officer

Novasign

Christoph Herwig

Professor of Bioprocessing
Engineering

Vienna University of Technology

Philip Probert

Head of Technical

CPI Bioloigics

Barbara Kraus

Head of Gene Therapy Process Development

Takeda

Ulrich Rümenapp

Head of Launch Preparation

Bayer

Barbara Kraus

Head of Gene Therapy Process Development

Takeda

 

Ulrich Rümenapp

Head of Launch Preparation

Bayer

 

Philip Probert

Head of Technical

CPI Bioloigics

 

>Forum Introduction<

Today’s Bioprocessing is the base of several emerging industries and technologies, including the production of therapeutic stem cells, gene therapy vectors, and new vaccines. Advances in Bioprocessing is a particular interest to the industry as it considerably shortens the development timeline, improves the final product and increase the productivity of Bio-manufacturing facilities.

Cparity’s World Smart Bioprocessing: Pharma 4.0 Summit is launching a world platform across the Pharma & Biopharmaceutical Manufacturing community to present their technological advances, to boost innovation and exchange insights on current challenges. The event will gather top leaders in a 3-day event, aiming to promote a high level participation to provide the appropriate environment for dialogue with peers from pharma, biotech, schools, and pharma suppliers to maximize our efforts and profit in the industry.

This Summit program comprises complex case studies, workshops, panels and breakouts. It will combine forward-thinking leaders from different industries to discuss a range of topics on Bioprocessing and Smart manufacturing. We will approach main challenges, innovations and new technologies.

Join our event to learn and get inspired from world leading industry experts and improve your business performance!

Key Topics

PRODUCT LIFE

CYCLE

– Transforming upstream bioprocessing: the bioreactor digital twin as an archetype of pharma 4.0

– Genetic stability

– Strategies for developing vaccines from early phase development to a commercial product

– Stakeholder perspectives on the cross-functional process of a new product launch

– Scale-up technologies: development and manufacturing processes and validation

– Evolution of product quality attributes during the upstream and downstream process

TECHNOLOGIZING ATMP/CELL

AND GENE THERAPY

– Lentiviral vector manufacturing and analytics – opportunities, challenges and ways forward

– The use of high-throughout technologies to facilitate cell line characterization and development

– Evaluation of novel harvest methods for the clarificiation of cell culture material

– Delivering a globally compliant allogeneic cell therapy for low back pain

– Optimising cell line development: applications for furthering biopharma r&d strateg

CONTINUOUS

BIOMANUFACTURING

– Digitalization platform and supervisory control for continuous integrated manufacture of monoclonal antibodies

– Development of continuous purification strategies for therapeutic bioparticles

– Integrated process modelling: a companion from process development to control strategy

– Digitalization and big data in biopharma – vice or virtue?

– Model-based control and integrated bio manufacturing processes

PHARMA 4.0/SMART

MANUFACTURING

– Biopharmaceutical process models in the digital age – how to make value out of data

– Analytical characterisation of novel high potency neurotoxin therapeutics

– Digitalisation of raw material data and application of data analytics to increase understanding and control variation automated material

– Traceability in end-to-end continuous biomanufacturing for batch disposition

– The new age of smart continuous manufacturing as market moves to commercial

PRODUCT LIFE

CYCLE

– Transforming upstream bioprocessing: the bioreactor digital twin as an archetype of pharma 4.0

– Genetic stability

– Strategies for developing vaccines from early phase development to a commercial product

– Stakeholder perspectives on the cross-functional process of a new product launch

– Scale-up technologies: development and manufacturing processes and validation

– Evolution of product quality attributes during the upstream and downstream process

CONTINUOUS

BIOMANUFACTURING

– Digitalization platform and supervisory control for continuous integrated manufacture of monoclonal antibodies

– Development of continuous purification strategies for therapeutic bioparticles

– Integrated process modelling: a companion from process development to control strategy

– Digitalization and big data in biopharma – vice or virtue?

– Model-based control and integrated bio manufacturing processes

PHARMA 4.0/SMART

MANUFACTURING

– Biopharmaceutical process models in the digital age – how to make value out of data

– Analytical characterisation of novel high potency neurotoxin therapeutics

– Digitalisation of raw material data and application of data analytics to increase understanding and control variation automated material

– Traceability in end-to-end continuous biomanufacturing for batch disposition

– The new age of smart continuous manufacturing as market moves to commercial

TECHNOLOGIZING ATMP/CELL

AND GENE THERAPY

– Lentiviral vector manufacturing and analytics – opportunities, challenges and ways forward

– The use of high-throughout technologies to facilitate cell line characterization and development

– Evaluation of novel harvest methods for the clarificiation of cell culture material

– Delivering a globally compliant allogeneic cell therapy for low back pain

– Optimising cell line development: applications for furthering biopharma r&d strateg

Who Should Attend

– Those working in technologies to scale up bioprocesses for biologics, vaccines, related species for clinical trials or scale-up to commercialization

– Pharma 4.0

– Engineering

– Principal scientist

– Research scientist

– Technical operations

– Technical development

– Biologics development

– Drug substance

– Quality

– Process development

– R&d engineer

– Cell line development

– Downstream processing

– Technical operations

– Technical development

– Biologics development

– Drug substance

– Quality

– Process development

– R&d engineer

– Cell line development

– Downstream processing

– Those working in technologies to scale up bioprocesses for biologics, vaccines, related species for clinical trials or scale-up to commercialization

– Pharma 4.0

– Engineering

– Principal scientist

– Research scientist

– Technical operations

– Technical development

– Biologics development

– Drug substance

– Quality

– Process development

– R&d engineer

– Cell line development

– Downstream processing

– Technical operations

– Technical development

– Biologics development

– Drug substance

– Quality

– Process development

– R&d engineer

– Cell line development

– Downstream processing

PLANT TOUR

THE TECHNISCHE UNIVERSITÄT BERLIN LAB OF THE FUTURE TOUR

The Technische Universität Berlin Lab of the Future is one of three international AI future laboratories in the world. The tour will be for an exclusive group of people. It will showcase the advance bioprocessing with AI, RPA, IOT.

DELEGATES WILL LEARN:

- Systematic bioprocess development
- Bioprocess scale down and scale up
- Bioprocess robustness analysis
- Development of digital models for your process
- Method development for robotic facilities
- Programming for laboratory robots from Simple to complex integrated Solutions​

Sponsors

Media Partners

The Venue

InterContinental
Berlin Hotel

Budapester Str. 2, 10787 Berlin, Germany
+49 30 26020

InterContinental Berlin Hotel

Budapester Str. 2, 10787 Berlin, Germany +49 30 26020

Cparity Event s r.o.

European Business Center,
Dukelských Hrdinů 564/34,
Prague 7 170 00,
Czech Republic
[email protected]
+420 210 022 094

Cparity Event LTD

19-21 Crawford Street,
W1H 1PJ,
London, England
[email protected]
+442031291774

Disclaimer